Pacira BioSciences' Interest Expenses fell 874.39% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 1935.59%. This contributed to the annual value of $16.6 million for FY2024, which is 1840.34% down from last year.
Per Pacira BioSciences' latest filing, its Interest Expenses stood at $4.3 million for Q3 2025, which was down 874.39% from $4.7 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Interest Expenses ranged from a high of $11.0 million in Q4 2022 and a low of $3.3 million during Q1 2024
Over the past 5 years, Pacira BioSciences' median Interest Expenses value was $4.7 million (recorded in 2025), while the average stood at $6.4 million.
As far as peak fluctuations go, Pacira BioSciences' Interest Expenses skyrocketed by 4759.27% in 2021, and later crashed by 6931.44% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Interest Expenses stood at $10.4 million in 2021, then increased by 5.93% to $11.0 million in 2022, then tumbled by 69.31% to $3.4 million in 2023, then surged by 38.13% to $4.7 million in 2024, then decreased by 8.57% to $4.3 million in 2025.
Its last three reported values are $4.3 million in Q3 2025, $4.7 million for Q2 2025, and $4.6 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value